1. Home
  2. ELDN vs UBFO Comparison

ELDN vs UBFO Comparison

Compare ELDN & UBFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • UBFO
  • Stock Information
  • Founded
  • ELDN 2004
  • UBFO 1987
  • Country
  • ELDN United States
  • UBFO United States
  • Employees
  • ELDN N/A
  • UBFO N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • UBFO Major Banks
  • Sector
  • ELDN Health Care
  • UBFO Finance
  • Exchange
  • ELDN Nasdaq
  • UBFO Nasdaq
  • Market Cap
  • ELDN 164.1M
  • UBFO 154.8M
  • IPO Year
  • ELDN N/A
  • UBFO N/A
  • Fundamental
  • Price
  • ELDN $3.50
  • UBFO $8.73
  • Analyst Decision
  • ELDN Strong Buy
  • UBFO
  • Analyst Count
  • ELDN 2
  • UBFO 0
  • Target Price
  • ELDN $12.50
  • UBFO N/A
  • AVG Volume (30 Days)
  • ELDN 1.4M
  • UBFO 21.9K
  • Earning Date
  • ELDN 11-11-2025
  • UBFO 10-16-2025
  • Dividend Yield
  • ELDN N/A
  • UBFO 5.33%
  • EPS Growth
  • ELDN N/A
  • UBFO N/A
  • EPS
  • ELDN 0.21
  • UBFO 0.65
  • Revenue
  • ELDN N/A
  • UBFO $45,922,000.00
  • Revenue This Year
  • ELDN N/A
  • UBFO N/A
  • Revenue Next Year
  • ELDN N/A
  • UBFO N/A
  • P/E Ratio
  • ELDN $16.22
  • UBFO $13.84
  • Revenue Growth
  • ELDN N/A
  • UBFO N/A
  • 52 Week Low
  • ELDN $2.32
  • UBFO $7.32
  • 52 Week High
  • ELDN $5.54
  • UBFO $10.49
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 70.99
  • UBFO 41.07
  • Support Level
  • ELDN $2.58
  • UBFO $8.48
  • Resistance Level
  • ELDN $2.71
  • UBFO $9.17
  • Average True Range (ATR)
  • ELDN 0.24
  • UBFO 0.27
  • MACD
  • ELDN 0.07
  • UBFO -0.05
  • Stochastic Oscillator
  • ELDN 72.69
  • UBFO 25.71

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

Share on Social Networks: